ARCHIVES

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

This article is from The Cancer Letter archive.

Vol. 14 No. 47 | December 2, 1988

Download PDF Visit The Full Archive

Related Articles

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

Cigarette use declining among high school students, report finds.

June 25, 2004